2418 indexable Healthcare companies headquartered in Canada, ranked by total equity funding and recent funding momentum. Combined disclosed equity funding of $5.3B across 230 funded companies, including 1 unicorn.
| # | Company | Funding | Valuation | Stage | Latest round | Employees | Founded | Momentum |
|---|---|---|---|---|---|---|---|---|
| 1 |
University Health Network
Chain of multi-speciality hospitals |
$107.1M | — | Funding Raised | Grant (prize money) Dec 2025 | 12,322 | 1998 | ↑ Active |
| 2 |
TerrAscend
Retailer of cannabis dispensaries and medical products |
$471.8M | — | Public | Post IPO May 2025 | 36 | 2017 | ↑ Active |
| 3 |
Arch BioPartners
Translates basic science research into products |
$7.6M | — | Public | Post IPO Mar 2026 | 17 | 1983 | ↑ Active |
| 4 |
Psyched Wellness
Manufacturer of wellness products |
$8.7M | — | Public | Post IPO Mar 2026 | 1,800 | 2019 | ↑ Active |
| 5 |
Corus Ortho
Corus Orthodontists - North American Partnership |
$14.7M | — | Series B | Series B Feb 2026 | 108 | 2019 | ↑ Active |
| 6 |
Algernon Pharmaceuticals
Developer of small molecules for chronic kidney disease and inflammatory bowel diseases |
$12.8M | — | Public | Post IPO Nov 2025 | 1 | 2015 | ↑ Active |
| 7 |
SRx Health
Provider of patient engagement services |
$15.2M | — | Series B | Series B Oct 2025 | 67 | 2013 | ↑ Active |
| 8 |
LSL Pharma Group
Integrated pharmaceutical company provides pharma products |
$12.6M | — | Public | Post IPO Sep 2025 | — | 2023 | ↑ Active |
| 9 |
Cizzle Brands
Health and wellness company offering hydration and nutrition products |
$787.5K | — | Public | Post IPO May 2026 | — | 2024 | ↑ Active |
| 10 |
Myomar Molecular
Provider of healthcare technology services |
$810.2K | — | Seed | Seed May 2026 | 3 | 2021 | ↑ Active |
| 11 |
Andira
Digital pharmacotherapeutic platform for providers |
$1.4M | — | Seed | Seed Feb 2026 | — | 2020 | ↑ Active |
| 12 |
Othership
Provider of immersive sauna and ice bath wellness experiences. These experiences aim to improve physical and mental well-being through the combined effects of heat and cold therapy. Various session types are offered, including self-guided and guided options, catering to different preferences and intentions. The sessions incorporate elements such as breathwork and essential oils to enhance the overall experience. A social aspect is also integrated, fostering community and connection among participants. The facilities include saunas, cold plunge tubs, and a relaxation area. |
$20.6M | — | Series A | Series A May 2025 | 46 | 2020 | ↑ Active |
| 13 |
Orion Biotechnology
Provider of biologic therapeutics for addressing obesity and metabolic disorders through the development of next-generation GPCRs |
$15.6M | — | Series A | Series A May 2025 | 21 | 2011 | ↑ Active |
| 14 |
Dentronic
Developer of robotic arm designed to automate dental assistive tasks |
$1M | — | Seed | Seed Mar 2026 | — | 2024 | ↑ Active |
| 15 |
RI-MUHC
Provider of cloud-based accounting and payroll solutions |
$4.6M | — | Funding Raised | Grant (prize money) Jul 2025 | 720 | 1997 | ↑ Active |
| 16 |
Sirona Biochem
Developer of therapeutics for the treatment of skincare |
$7.4M | — | Public | Post IPO Apr 2025 | 11 | 2006 | ↑ Active |
| 17 |
FUNCTIONALABGROUP
Manufacturer of dermocosmetics |
$12.2M | — | Series A | Series A Apr 2025 | 12 | 2012 | ↑ Active |
| 18 |
Decibel Cannabis
Producer of cannabis products |
$20.5M | — | Public | Post IPO Nov 2024 | 171 | 2008 | ↑ Active |
| 19 |
Optimi Health
Manufacturer of vegan protein |
$4.5M | — | Public | Post IPO Jul 2025 | — | 2020 | ↑ Active |
| 20 |
UniDoc Health
Provider of tele healthcare services |
$1.4M | — | Public | Post IPO Oct 2025 | — | 2008 | ↑ Active |
| 21 |
ImmunoPrecise Antibodies
CDMO focused on antibody discovery and pre-clinical services |
$18.4M | — | Public | Post IPO Jul 2024 | 80 | 1989 | ↑ Active |
| 22 |
Simply Solventless
Retailer of CBD concentrates |
$7.7M | — | Public | Post IPO Feb 2025 | 10 | 2020 | ↑ Active |
| 23 |
MTL Cannabis
Manufacturer and distributor of medical cannabis products |
$1.4M | — | Acquired | Post IPO Sep 2025 | — | 2018 | ↑ Active |
| 24 |
CanadaBis
M&A advisory firm focused on the cannabis industry |
$473.1K | — | Public | Post IPO Dec 2025 | — | 2016 | ↑ Active |
| 25 |
HEXO
Brand of cannabis based products |
$245.9M | — | Acquired | Post IPO Jun 2023 | 689 | 2013 | — |
| 26 |
Twig Fertility
Online platform offering multiple services for fertility care |
$6.2M | — | Series A | Series A Jan 2025 | 27 | 2020 | ↑ Active |
| 27 |
Voyageur Pharmaceuticals
Manufacturer of barium and iodine generic radiographic drugs |
$3.9M | — | Public | Grant (prize money) Feb 2025 | — | 2013 | ↑ Active |
| 28 |
KDA
Provider of digital and artificial intelligence solutions, specialized medical education and training, and consulting in the healthcare industry |
$2.4M | — | Public | Post IPO May 2025 | — | 2009 | ↑ Active |
| 29 |
Arbutus Medical
Manufacturer of orthopedic surgical tools and devices |
$2.3M | — | Seed | Seed Mar 2025 | 25 | 2014 | ↑ Active |
| 30 |
Christina Lake Cannabis
Provider of sun-grown cannabis flower, oil cannabinoids, hemp-based extracts, and derivatives |
$1.4M | — | Public | Post IPO Apr 2025 | 12 | 2018 | ↑ Active |
| 31 |
Britannia Life Sciences
Research lab providing product development, QA, safety, and regulatory compliance services |
$5.4M | — | Public | Post IPO Nov 2024 | 5 | 2000 | ↑ Active |
| 32 |
CHUSJ
Provider of mother-child healthcare services and research |
$2M | — | Funding Raised | Grant (prize money) Apr 2025 | 2,581 | 2006 | ↑ Active |
| 33 |
dentalcorp
Provider of continuing education and skill development services for dentists |
$500M | — | Acquired | Series D Feb 2021 | 8,550 | 2011 | — |
| 34 |
Auxly
Provider of platform to manage cannabis manufacturing operations in industries |
$132.5M | — | Public | Post IPO Feb 2023 | 420 | 1987 | — |
| 35 |
Lumiera Health Innovation
Manufacturer of natural healthcare products |
$2M | — | Acquired | Post IPO Feb 2025 | — | 2020 | ↑ Active |
| 36 |
Medexus Pharmaceuticals
Manufacturer of pharmaceutical drugs catering to rheumatology, immunology, and oncology among others |
$122.8M | — | Public | Conventional Debt Sep 2022 | 98 | 2004 | — |
| 37 |
The BC Bud Co
Provider of cannabis cultivators services |
$1.6M | — | Public | Post IPO Jan 2025 | 6 | 2019 | ↑ Active |
| 38 |
AtomVie
Provider of diversified CDMO services for radiotherapeutics |
$90M | — | Series A | Series A Jun 2023 | 92 | 2021 | — |
| 39 |
Flowr
Provider of cannabis products |
$196.4M | — | Public | Post IPO Jul 2021 | — | 2017 | — |
| 40 |
Medigroup Health Services
Network of medical clinics, pharmacies, and home care services provider |
$1.5M | — | Seed | Seed Feb 2025 | 31 | 2008 | ↑ Active |
| 41 |
VetCare
Standalone veterinary clinic |
$100M | — | Series D | Series D Jan 2023 | 32 | 2016 | — |
| 42 |
Molecule
Brand of cannabis infused beverage products |
$2.2M | — | Acquired | Seed Nov 2024 | 13 | 2018 | ↑ Active |
| 43 |
Allied Health
Medical cannabis supplier delivering pharmaceutical-grade solutions worldwide |
$1.4M | — | Public | Post IPO Nov 2024 | 165 | 2019 | ↑ Active |
| 44 |
HLS Therapeutics
Developer of branded pharmaceutical drugs |
$350M | — | Public | Post IPO Jun 2019 | 96 | 2015 | — |
| 45 |
Valeo Pharma
Canadian specialty pharma company |
$25M | — | Acquired | Post IPO Aug 2023 | 121 | 2003 | — |
| 46 |
Knight Therapeutics
Acquires, licenses, and commercializes prescription pharmaceuticals |
$244.1M | — | Public | Conventional Debt Feb 2019 | 831 | 2014 | — |
| 47 |
Green Tank Technologies
Private label brand of vape products |
$30.2M | — | Series B | Series B Mar 2023 | 78 | 2015 | — |
| 48 |
adMare BioInnovations
Provider of biopharma consulting services |
$92M | — | Funding Raised | Grant (prize money) Mar 2022 | 152 | 2019 | — |
| 49 |
Ring Rescue
Manufacturer of air pressure measurement device to reduce finger swelling |
$570.4K | — | Seed | Seed Jan 2025 | 15 | 2010 | ↑ Active |
| 50 |
High Q Technologies
Developer of quantum-enabled electron paramagnetic resonance systems for protein analysis |
$10.2M | — | Seed | Seed Feb 2024 | 24 | 2013 | — |
Chain of multi-speciality hospitals
Retailer of cannabis dispensaries and medical products
Arch Biopartners business model is based on working closely with the scientific community, universities and research institutions to advance and build the value of select preclinical technologies, develop the most promising intellectual property, and create value for its investors. Arch has established a diverse portfolio that includes MetaMx (synthetic peptides that target and attach to BTICs and invasive glioma cel
Manufacturer of wellness products
Are you an Orthodontist seeking a different type of partnership than the traditional DSO? Learn more about Corus today!
Algernon Pharmaceuticals is a developer of small molecules for chronic kidney disease and inflammatory bowel diseases. The company is using a drug repurposing strategy to discover drugs. The lead candidate, NP-135 is an antifibrotic compound being investigated for NASH (phase 1). Other molecules are in phase 1 trials for CKD and IBD.
Provider of patient engagement services
Groupe LSL Pharma is a Canadian integrated pharmaceutical company that focuses on innovation in life science products to support the Canadian population. They have recently announced new orders with an annual revenue potential exceeding $2.6 million.
Cizzle Brands is a company dedicated to elevating the game in health and wellness, offering innovative hydration solutions for athletes and individuals alike. They aim to help individuals achieve their full potential through their products and services.
Provider of healthcare technology services
Digital pharmacotherapeutic platform for providers. It is a platform for the discovery and creation of natural chemicals with the potential for medicinal usage.
{}
Rankings are computed by Radar (Fliar BI) from the Radar company master and are updated periodically. Funding and momentum scores use disclosed equity-funding data only. Figures may lag private rounds. Last updated 2026-06-16.
_1551341913159.png){kind=logo}
